# Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure

> **NCT01857635** · — · COMPLETED · sponsor: **University of Lausanne Hospitals** · enrollment: 20 (actual)

## Conditions studied

- Hypercapnic Respiratory Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01857635
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857635, "Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01857635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*